Species-dependent binding of disopyramide enantiomers.

The research article explores how the binding of disopyramide, a medication used to treat certain types of serious irregular heartbeat patterns, varies between different animal species. The study found that enantiomers (mirror image forms) of disopyramide bind differently depending on the species and that this difference is due to variations in association constants.

Disopyramide Binding and Species Divergence

• The research examined how serum protein binds to enantiomers of disopyramide in several animal species. The species studied included humans, gorillas, pigs, cows, sheep, horses, and goats.
• In humans, gorillas, and pigs, the S-(+)-disopyramide was found to be more strongly bound to serum protein than the R-(-)-enantiomer. This pattern was reversed in cows and sheep.
• The study notes that these species-dependent differences in enantiomer binding to serum protein are due to variations in association constants, which characterize the strength of binding between two participating species in a chemical reaction.

No Enantioselective Differences in Certain Species

• In horse and goat’s serum proteins, and in cow and pig’s albumin, there were no noted enantioselective differences in disopyramide binding.
• Disopyramide was strongly bound to two sites on horse albumin. The primary binding site on horse albumin showed an association constant of 1.3 x 10(7) M-1.

Displacement of Disopyramide and Implications

• The study also tested the effect of certain substances on disopyramide binding. A compound named Tris-(2-butoxyethyl)phosphate could displace disopyramide from its binding sites on horse albumin and on serum protein from humans, gorillas, cows, and pigs at certain concentrations.
• However, warfarin and diazepam had no effect on disopyramide binding in the species tested.
• The researchers concluded that the binding of disopyramide is species-dependent. They suggest that alpha 1-acid glycoprotein could be the protein primarily responsible for the moderate to high binding of disopyramide enantiomers.
• They also posit that the binding sites for disopyramide on horse albumin may be unique, suggesting potential species-specific physiological mechanisms that could be further studied for drug development and treatment strategies.